Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is 11.12% vs 3.34% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is 50.63% vs 9.38% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is 16.55% vs 0.29% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is -33.97% vs -20.85% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
Compare Quarterly Results Of Swedish Orphan Biovitrum AB With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is -8.14% vs 0.58% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 11.12% vs 3.34% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -29.22% vs 164.32% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 50.63% vs 9.38% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is -14.21% vs -68.58% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 16.55% vs 0.29% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is -6.49% vs 10.12% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -33.97% vs -20.85% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025






